Search research articles
Contact Us
Filters
Showing results (41-50 of 134) with videos related to
Page
of 14
Sort By:
Inflammatory Bowel Diseases
|
October 19, 2016
The Use and Efficacy of Fecal Microbiota Transplantation for Refractory Clostridium difficile in Patients with Inflammatory Bowel Disease
Robert J Gianotti, Alan C Moss
Gastroenterology & Hepatology
|
May 27, 2017
Fecal Microbiota Transplantation: From <i>Clostridium difficile</i> to Inflammatory Bowel Disease
Robert J Gianotti, Alan C Moss
Gastroenterology
|
June 16, 2007
Impotent immune system: an underlying problem in Crohn's disease
Alan C Moss, Richard J Farrell
Journal of Crohn'S & Colitis
|
January 15, 2016
Systematic Review and Meta-Analysis: Serum Infliximab Levels During Maintenance Therapy and Outcomes in Inflammatory Bowel Disease
Clare Moore, Gillian Corbett, Alan C Moss
In Silico Biology
|
March 21, 2012
In silico analysis of T-bet activity in peripheral blood mononuclear cells in patients with inflammatory bowel disease (IBD)
Nielsen Q Fernandez-Becker, Alan C Moss
Drugs
|
May 20, 2008
Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes
Nielsen Q Fernandez-Becker, Alan C Moss
Expert Review of Clinical Immunology
|
July 3, 2010
Once-daily mesalamine granules for ulcerative colitis
Garrett Lawlor, Awais Ahmed, Alan C Moss
Inflammatory Bowel Diseases
|
April 13, 2011
Drug development in inflammatory bowel disease: the role of the FDA
Conor Lahiff, Sunanda Kane, Alan C Moss
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 6, 2017
Reply
John Mark B Gubatan, Alan C Moss
Gastrointestinal Endoscopy
|
July 29, 2017
Impact of mucosal inflammation on risk of colorectal neoplasia in patients with ulcerative colitis: a systematic review and meta-analysis
Brisas M Flores, Anthony O'Connor, Alan C Moss
Page
of 14
Search research articles
Search
Showing results (41-50 of 134) with videos related to
Sort By:
Page
of 14
Inflammatory Bowel Diseases
|
October 19, 2016
The Use and Efficacy of Fecal Microbiota Transplantation for Refractory Clostridium difficile in Patients with Inflammatory Bowel Disease
Robert J Gianotti, Alan C Moss
Gastroenterology & Hepatology
|
May 27, 2017
Fecal Microbiota Transplantation: From <i>Clostridium difficile</i> to Inflammatory Bowel Disease
Robert J Gianotti, Alan C Moss
Gastroenterology
|
June 16, 2007
Impotent immune system: an underlying problem in Crohn's disease
Alan C Moss, Richard J Farrell
Journal of Crohn'S & Colitis
|
January 15, 2016
Systematic Review and Meta-Analysis: Serum Infliximab Levels During Maintenance Therapy and Outcomes in Inflammatory Bowel Disease
Clare Moore, Gillian Corbett, Alan C Moss
In Silico Biology
|
March 21, 2012
In silico analysis of T-bet activity in peripheral blood mononuclear cells in patients with inflammatory bowel disease (IBD)
Nielsen Q Fernandez-Becker, Alan C Moss
Drugs
|
May 20, 2008
Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes
Nielsen Q Fernandez-Becker, Alan C Moss
Expert Review of Clinical Immunology
|
July 3, 2010
Once-daily mesalamine granules for ulcerative colitis
Garrett Lawlor, Awais Ahmed, Alan C Moss
Inflammatory Bowel Diseases
|
April 13, 2011
Drug development in inflammatory bowel disease: the role of the FDA
Conor Lahiff, Sunanda Kane, Alan C Moss
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 6, 2017
Reply
John Mark B Gubatan, Alan C Moss
Gastrointestinal Endoscopy
|
July 29, 2017
Impact of mucosal inflammation on risk of colorectal neoplasia in patients with ulcerative colitis: a systematic review and meta-analysis
Brisas M Flores, Anthony O'Connor, Alan C Moss
Page
of 14